Bill > HR235

This bill aims to address the issue of triple-negative breast cancer, which is a more aggressive form of breast cancer that disproportionately affects minority women, particularly African-American and Hispanic women. The key provisions of the bill include: 1. Expanding, intensifying, and coordinating research on triple-negative breast cancer at the National Institutes of Health, focusing on areas such as prevalence, costs, and prevention/treatment methods. 2. Developing and disseminating public education campaigns on triple-negative breast cancer, including information on its incidence, elevated risk for minority women, and available treatment options. 3. Requiring the dissemination of information on triple-negative breast cancer to healthcare providers to ensure they remain informed about current knowledge on this type of cancer, particularly the elevated risk for minority women. The bill also defines "minority women" as those who are members of a racial and ethnic minority group, as defined in the Public Health Service Act.

Business and Industry, Health and Social Services

https://www.congress.gov/bill/118th-congress/house-bill/235/all-info